Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001641172-25-003854
Filing Date
2025-04-11
Accepted
2025-04-11 16:40:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 273504
2 form424b4_005.jpg GRAPHIC 8932
3 form424b4_001.jpg GRAPHIC 26425
4 form424b4_002.jpg GRAPHIC 38678
5 form424b4_003.jpg GRAPHIC 40636
6 form424b4_004.jpg GRAPHIC 39567
  Complete submission text file 0001641172-25-003854.txt   487629
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-286385 | Film No.: 25832708
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)